BEIJING (Reuters) -Chinese artificial intelligence startup Moonshot AI released a new open-source AI model on Friday, joining a wave of similar releases from local rivals, as it seeks to reclaim its position in the competitive domestic market.

A lot has been said about the emerging technology's world-changing potential: Its ability to create stunningly realistic images and videos, ace the LSAT and the MCAT, and complete rote research tasks. You could argue it's ready to augment — or even replace — entry-level jobs.

Yes, this is a pharmaceutical outfit, but yes, it's also an AI name. The company uses artificial intelligence to predict how a particular drug might perform or plan how the underlying molecule might be best fabricated, saving time as well as money on clinical trials that may end in failure.

Kimi K2 reflects a broader trend in the AI sector towards open-source development to improve efficiency and gain wider product adoption.

Tax incentives contained in the sweeping tax and budget bill Trump signed on July 4 could provide a fresh boost to AI chipmakers.

The AI chip king, Nvidia ( NVDA 1.10%), is seemingly invincible and is viewed as the ultimate pick-and-shovel play for AI. Even when challenges present themselves and the stock stumbles, it doesn't last very long.

A&O Shearman didn’t just co-develop agentic AI tools with Harvey—it also modernized its business model to stay competitive in the age of AI disruption.

AI is a new tool to help investors analyze data, but can it beat the stock market? Here's how a chatbot's stock picks fared in June.

Key Points Surging demand for optical components in AI data centers has helped Lumentum record solid growth.Analysts expect Lumentum to maintain healthy growth levels over the next couple of years.Despite the stock's strong recent gains,

Coinbase has teamed up with Perplexity AI to provide real-time data on the crypto market. The first step is to add COIN50 for price analysis.